Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,381.35
(
-0.37%
)
US TECH 100
28,129.20
(
-0.80%
)
Dow Jones
49,448.49
(
-0.16%
)
Brent Oil
107.79
(
0.29%
)
Bitcoin
76,272.13
(
-1.47%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biocqr post# 213755

Thursday, 09/21/2017 1:04:31 PM

Thursday, September 21, 2017 1:04:31 PM

Post# of 257580
Curious that ICPT is being punished twice for essentially the same news as what was posted two weeks ago (#msg-134545079).

I'm not complaining, however, since I think Ocaliva is a bad drug that probably won't be approved for NASH.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today